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the Oﬃce of National Statistics. Age- and gender standardised mortality
rates were compared to the general population for all-cause mortality
and disease-speciﬁc mortality (cardiovascular, cancer-related, respiratory,
gastrointestinal and dementia-associated death). Multi-variable Cox re-
gression models including demographic and socioeconomic characteristics,
self-report comorbidity, hip or knee pain and disability were used to
determine whether these characteristics were associated with increased
mortality. Multiple imputation was used to address missing covariate data.
Results: We found an excess all-cause mortality in osteoarthritis patients
compared to the general population with an SMR of 1.55 (95% CI 1.41 to
1.70). Excess mortality was observed for all disease-speciﬁc mortalities, but
was particularly pronounced for cardiovascular (SMR 1.71, 95% CI 1.49 to
1.98) and dementia-associated mortality (SMR 1.99, 95% CI 1.22 to 3.25).
The Table presents multivariable hazard ratios for the association of dif-
ferent baseline characteristics with all-cause mortality. Increased mortality
was found with older age, male gender, self-reported history of diabetes,
cancer or cardiovascular disease, and walking disability (P≤0.002), but not
with previous joint replacement, obesity, depression, chronic inﬂammatory
disease, eye disease and presence of pain at baseline.
Conclusions: Osteoarthritis patients are at higher risk of death for any
cause than the general population, which is particularly pronounced for
cardiovascular and dementia-associated mortality. A history of diabetes,
cancer or cardiovascular disease and the presence of walking disability at
baseline increase the risk of all-cause mortality.
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Purpose: The Osteoarthritis Research Society International (OARSI) has
recently published 25 recommendations for the treatment of OA of the hip
and knee following a critical appraisal of existing guidelines, identiﬁcation
of a core set of recommendations, and a systematic review of the evidence
for relevant therapies. The purpose of this study was to audit current
practice in Scotland for non-pharmacological (NP) and pharmacological (P)
treatments in patients with OA hip or knee awaiting arthroplasty against
the OARSI recommendations.
Methods: Patients with OA hip or knee awaiting arthroplasty in 2009/10
were interviewed by an experienced musculoskeletal nurse in an Or-
thopaedic Outpatient setting. Demographic data, duration of symptoms
and comorbidities were recorded. Standardised questions relating to 20
audit criteria were based on the OARSI recommendations for NP and P
treatments. Information obtained was recorded using an audit support
tool adapted from the National Institute for Health and Clinical Excellence
(NICE).
Results: 200 Caucasian patients (87 male, 113 female), mean age 67 years
(range 36-91) were interviewed. 110 had hip OA and 90 knee OA. The
duration of symptoms prior to elective arthroplasty was 6 (range 0.5-39)
years for hip OA and 9 (0.5-50) years for knee OA. Most patients were
overweight, BMI >25 in 73% of those with hip OA and 80% knee OA;
and many were obese, BMI >30 in 33% of hip OA and 53% of knee OA
patients. Most (70% hip OA, 78% knee OA) had received a combination of P
and NP therapies but written information about the objectives of therapy
and the need for lifestyle modiﬁcations had been given to less than half.
Only 43% of patients with a BMI >25 had ever been encouraged to lose
weight, and only 20% maintained weight loss. Advice to exercise had been
given to 67% of patients and 61% had been referred to a physiotherapist
for assessment and instruction in appropriate exercises. While 90% had
been instructed in muscle strengthening exercises, 84% in range of motion
exercises and 56% were given pool exercises; advice about aerobic ﬁtness
exercise was given to only 31% and advice on appropriate footwear to only
23%. Ambulatory aids were used by 30% of patients but other NP modalities
of therapy were seldom employed: thermal treatments 26%, acupuncture
15%, TENS 6%, shoe insoles 9%, knee braces 2% and regular telephone
contact in 3%. Patients > 75 years of age were referred to a physical
therapist less frequently (46%) and used NP modalities of treatment less
often. All patients had used analgesic drugs but acetaminophen was the
initial choice in only 55% and 81% had used preparations containing weak
opioids. Oral NSAIDs were taken by 64% of patients, in 43% without gastric
protection, and 33% had experienced upper GI symptoms. Selective COX-2
inhibitors were only used by 5% of patients. Topical NSAIDs were employed
by 31% of patients, more often as an adjunct than as an alternative to
oral medication. Capsaicin was used by 4% of patients. Nutraceuticals were
taken by 40% of patients, either as glucosamine sulphate alone (24%) or
in combination with chondroitin sulphate. 19% of patients with knee OA
had had at least one intra-articular (IA) corticosteroid injection and 5% had
undergone joint lavage, but IA hyaluronate injections were not used.
Conclusions: In many patients with OA hip and knee coming to arthro-
plasty in Scotland OARSI recommendations for P, and particularly NP
treatment, have never been implemented. The audit suggests that there
is a need for dissemination of the guidelines, for the development of
standards of care and especially for overcoming barriers to provision of
core therapies.
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Purpose: Being overweight is a known risk factor for osteoarthritis (OA).
Whether there are differences in risk factors for, and symptoms of, OA
between overweight people and normal weight people is not yet known.
We aim to identify which risk factors and symptoms are associated with
the prevalence of radiological knee OA (ROA, Kellgren & Lawrence score≥2)
in people with high BMI (≥27) and in people with normal BMI (<27) and if
these differ between the two groups.
Methods: Data of the RS-III-1 cohort of the Rotterdam study was used
(a population based cohort study). Eligible participants were aged 45-60
years and had an available knee X-ray. In total 1242 people with normal
BMI (mean age 54.4, 59.7% females) and 1224 with high BMI (mean age
54.8, 53.0% females) were included. Univariate logistic regression analysis
was used to test potential risk factors for knee ROA in people with high
vs. normal BMI. Symptoms and female hormonal speciﬁc risk factors were
tested in women only.
Tested potential risk factors were: age, gender, BMI, hip ROA, knee trauma,
diabetes, and varus alignment in one or both knees. In women-only addi-
tional risk factors were tested: menopausal (MP-) status, age at menarche
≥ 12 years, waist-hip ratio, and Heberden nodes (HN). Tested symptoms
were: WOMAC pain score, knee morning stiffness, limited extension (vs.
normal/hyper), and pain on palpation.
Risk factors and symptoms differing in statistical signiﬁcance between the
groups were tested for interaction with BMI using multivariate logistic
regression analysis. All outcomes were adjusted for age and BMI.
Results: Knee ROA was present in 5.8% in the normal BMI group and 9.0%
in the high BMI group.
In people with normal BMI the statistically signiﬁcant risk factors were:
age (Odds Ratio=1.08), and BMI (OR=1.16). In women-only these were:
MP-status (OR=3.98), and age at menarche (OR=0.39). The only statistically
signiﬁcant symptom was limited extension (OR=2.44).
Statistically signiﬁcant risk factors in the high-BMI group were: age
(OR=1.08), BMI (OR=1.13), and knee trauma (OR=1.61). In women-only this
was HN (OR=2.19). Statistically signiﬁcant symptoms were: WOMAC pain
(OR=5.14), morning stiffness (OR=4.67), and limited extension (OR=2.65).
Differences between the normal BMI group vs. the high BMI group in
signiﬁcant relationships were seen in the following risk factors: knee
trauma (BMI<27 OR=1.27 vs. BMI≥27 OR=1.61), MP-status (3.98 vs. 1.31),
age at menarche (0.39 vs. 0.59), and HN (1.65 vs. 2.19). For symptoms
differences in signiﬁcant relationships were seen in: WOMAC pain (2.52 vs.
5.14), morning stiffness (1.90 vs. 4.67), and limited extension (2.44 vs. 2.65.
All risk factors and symptoms that differ in statistical signiﬁcance were
formally tested for interaction with BMI; none of the interactions were
statistically signiﬁcant.
Conclusions: Risk factors for, and symptoms of, knee ROA do differ be-
tween people with normal vs. high BMI. There are strong indications that:
1) in overweight women morning stiffness is much stronger related to
having knee ROA than in non-overweight women and 2) in non-overweight
women is being post-menopausal related to having knee ROA, but not in
overweight women.
